The influence of thyroid hormone medication on intra-therapeutic half-life of 131I during radioiodine therapy of solitary toxic thyroid nodules
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The influence of thyroid hormone medication on intra-therapeutic half-life of 131I during radioiodine therapy of solitary toxic thyroid nodules ; volume:12 ; number:1 ; day:17 ; month:8 ; year:2022 ; pages:1-7 ; date:12.2022
Scientific reports ; 12, Heft 1 (17.8.2022), 1-7, 12.2022
- Creator
-
Happel, Christian
Kranert, Wolfgang Tilman
Bockisch, Benjamin
Sabet, Amir
Grünwald, Frank
Groener, Daniel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-18170-3
- URN
-
urn:nbn:de:101:1-2022110419184246351829
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Happel, Christian
- Kranert, Wolfgang Tilman
- Bockisch, Benjamin
- Sabet, Amir
- Grünwald, Frank
- Groener, Daniel
- SpringerLink (Online service)
Other Objects (12)
Determination of effective half-life of 131I in thyroid cancer patients using remote dose-rate meter
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
The EANM guideline on radioiodine therapy of benign thyroid disease
Biophysical studies of radioiodine metabolism during therapy of Autonomous Functioning Thyroid Nodule
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma
The clinical significance of remnant thyroid tissue in thyroidectomized differentiated thyroid cancer patients on 131I-SPECT/CT
Biophysical studies of radioiodine metabolism during therapy of autonomous fFunctioning thyroid nodule
The role of miR-139-5p in radioiodine-resistant thyroid cancer
Heath-related quality of life in thyroid cancer patients following radioiodine ablation
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Determination of effective half-life of 131I in thyroid cancer patients using remote dose-rate meter
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
The EANM guideline on radioiodine therapy of benign thyroid disease
Biophysical studies of radioiodine metabolism during therapy of Autonomous Functioning Thyroid Nodule
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma
The clinical significance of remnant thyroid tissue in thyroidectomized differentiated thyroid cancer patients on 131I-SPECT/CT
Biophysical studies of radioiodine metabolism during therapy of autonomous fFunctioning thyroid nodule
The role of miR-139-5p in radioiodine-resistant thyroid cancer
Heath-related quality of life in thyroid cancer patients following radioiodine ablation
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Determination of effective half-life of 131I in thyroid cancer patients using remote dose-rate meter
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
The EANM guideline on radioiodine therapy of benign thyroid disease
Biophysical studies of radioiodine metabolism during therapy of Autonomous Functioning Thyroid Nodule
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma
The clinical significance of remnant thyroid tissue in thyroidectomized differentiated thyroid cancer patients on 131I-SPECT/CT
Biophysical studies of radioiodine metabolism during therapy of autonomous fFunctioning thyroid nodule
The role of miR-139-5p in radioiodine-resistant thyroid cancer
Heath-related quality of life in thyroid cancer patients following radioiodine ablation
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer